ArticleEuropean thyroid journal2025

Rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.

Emmanuel Martinod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.